P53 Upregulated Modulator of Apoptosis (CT) Blocking Peptide

p53 Upregulated Modulator of Apoptosis (CT) Blocking Peptide

Product No.: P156

[product_table name="All Top" skus="P156"]

- -
- -
Target
p53 Upregulated Modulator of Apoptosis
Product Type
Blocking Peptide
Alternate Names
PUMA, bbc3

- -
- -
Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 180 to 193 of Human PUMA protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
14 amino acids near the carboxy terminus of human PUMA.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
P53 Upregulated Modulator of Apoptosis peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details

References & Citations

1. Wang L, Guo Y, Huang W-J, et al. CARD10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-?B. J. Biol. Chem. 2001; 276:21405-9. 2. Fanning AS and Anderson JM. Protein modules as organizers of membrane structure. Curr. Opin. Cell Biol. 1999; 11:432-9. 3. Fischer KD, Tedford K, Wirth T. New roles for Bcl10 in B-cell development and LPS response. Trends Immunol. 2004; 25:113-6. 4. Stilo R, Liguoro D, Di Jeso B, et al. Physical and functional interaction of CARMA1 and CARMA3 with I? kinase ?-NF-?B essential modulator. J. Biol. Chem. 2004; 279:34323-31.
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.